Childhood poisoning involving transdermal nicotine patches

A Woolf1, K Burkhart, T Caraccio

  • 1Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Department of Medicine, Children's Hospital, Boston, Massachusetts; Massachusetts Poison Control System, Boston, Massachusetts, USA.

Pediatrics
|May 1, 1997
PubMed

Insights

Unintentional exposure to transdermal nicotine patches (TNP) in children typically involves used patches and results in mild, transient symptoms. Most cases require only basic decontamination and supportive care, with full recovery reported.

Area of Science:

  • Toxicology
  • Pediatric Emergency Medicine
  • Public Health Surveillance

Background:

  • Transdermal nicotine patches (TNP) are used for smoking cessation.
  • Accidental pediatric exposure to TNPs can occur through dermal contact or ingestion.
  • Understanding the risks associated with TNP exposure in children is crucial for public health and clinical management.

Observation:

  • A prospective case series analyzed 36 TNP exposures in children aged 0-15 years reported to poison centers over 24 months.
  • Exposures involved dermal contact with intact or used patches (18 cases) or oral exposure via biting/swallowing patch components (18 cases).
  • No specific brand of TNP was associated with increased symptom severity.

Findings:

  • Symptomatic children (39%) experienced gastrointestinal distress, weakness, dizziness, or localized rashes.
  • Symptom development after dermal exposure correlated with an estimated nicotine dose of ≥0.10 mg.
  • Ten children required emergency department visits, and two were hospitalized, with all patients making a full recovery.

Implications:

  • Unintentional TNP exposures in young children are often associated with used patches and are generally transient.
  • Management primarily involves skin decontamination and supportive care.
  • Continued surveillance of inadvertent TNP exposures in children is recommended to validate these findings and inform safety guidelines.
Abstract

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...